Toyobo
Toyobo (Japan) is linked to 1 FDA-registered manufacturing site. 12 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Toyobo: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/toyobo
Overview
Toyobo is a chemical manufacturer headquartered in Ofukacho, Japan.
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to Toyobo, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
12 FDA enforcement records linked to this company.
- warning_letter2021-08-19
FDA Warning Letter (drug product)
- 4832021-02-25
Investigations of discrepancies, failures
- 4832021-02-25
Environmental Monitoring System
- 4832021-02-25
Habits of good sanitation & health
- 4832021-02-25
Weights and measures of components used
- 4832021-02-25
SOPs not followed / documented
- 4832021-02-25
Training--operations, GMPs, written procedures
- 4832021-02-25
Written record of investigation incomplete
- 4832021-02-25
Procedures not in writing, fully followed
- 4832021-02-25
Computer control of master formula records
- 4832021-02-25
Complete test data included in records
- 4832021-02-25
Suitability of testing methods verified
Is this Toyobo?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.